At the 2025 Veeva Commercial Summit Europe, experts touted the benefits of AI but stressed the importance of data and ...

The commercial teams of pharmaceutical companies are looking for more data analytics and business insights and they’re willing to spend more money to do it. Those are some of the findings of a recent ...

BALLERUP, Denmark--(BUSINESS WIRE)--As part of LEO Pharma’s transformation towards becoming a global leader in medical dermatology, the company today announced a refocused commercial structure to ...

TIBURON, Calif., Oct. 17, 2025 /PRNewswire/ -- ProclaimRx™ is an enterprise-grade AI platform that turns overwhelming pharma data into real-time, decision-ready intelligence—powered by the PLAiTO™ ...

When applied responsibly, AI empowers medical, commercial, and access teams to make faster, evidence-based decisions and ...

Company expands leadership team as customer base grows and platform drives measurable commercial impact As chief commercial officer, Gunn leads adoption of ODAIA's AI platform. He brings over two ...

The pharmaceutical industry is experiencing a profound transformation in how it approaches commercial decision-making and insights delivery with a big wave of technology and AI at the doorstep. Market ...

The pharmaceutical industry is undergoing a monumental shift driven by data, analytics, and artificial intelligence (AI). These technologies are enabling companies to enhance efficiency, drive ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...

Evoke Pharma, Inc. has appointed Greg Pyszczymuka to its Board of Directors as of February 20, 2025, marking the second addition to the board from Nantahala Capital Management, reflecting their ...

Traditionally, pharmaceutical companies’ interactions with healthcare professionals (HCPs) have been highly personalized — primarily via face-to-face, in-office visits. Recently, however, this model ...

COPENHAGEN, Denmark, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), today announced the U.S. commercial launch of SKYTROFA (lonapegsomatropin-tcgd), its once-weekly treatment ...